At the end of September Cantor Fitzgerald analyst Brian White said it had been “another good year” for veterinary drug firm Dechra Pharmaceuticals (LON:DPH), following its annual results. Friday is expected to bring a trading update for the current ...
Dechra Pharmaceuticals PLC (LSE: symbol DPH) announces the conditional acquisition of the entire share capital of Putney, Inc, a leading developer of generic companion animal pharmaceuticals in the US, based in Portland, Maine.
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have been assigned a consensus recommendation of “Buy” from the eight research firms that are currently covering the company.
The Board of Dechra Pharmaceuticals PLC (LSE:DPH), issues the following unaudited Trading Update ahead of the Group's half-year financial results for the period ended 31 December 2015, which will be announced on Monday, 22 February 2016.